Relevant Publications
2022
E. Gustafson, E. Gijbels, B. dos Santos Rodrigues, V. Vilas-Boas*, M. Vinken* (2022). Adverse outcome pathways as versatile tools in liver toxicity testing. In: E. Benfenati (eds) In Silico Methods for Predicting Drug Toxicity. Methods in Molecular Biology, vol 2425. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1960-5_20 (*co-senior authors)
2021
V. Vilas-Boas*, E. Gijbels*, K. Leroy, A. Pieters, A. Baze, C. Parmentier, M. Vinken (2021). Primary human hepatocyte spheroids as tools to study the hepatotoxic potential of non-pharmaceutical chemicals. International Journal of Molecular Sciences 22(20): 11005 (*co-first authors)
V. Vilas-Boas, M. Vinken (2021). Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models. Archives of Toxicology 95(1): 27-52
2020
E. Gijbels, V. Vilas‐Boas, P. Annaert, T. Vanhaecke, L. Devisscher, M. Vinken (2020). Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Archives of Toxicology 93(5): 1169-1186
V. Vilas-Boas, E. Gijbels, J. Jonckheer, E. De Waele, M. Vinken (2020). Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition. Environment International 136: 105422
R. Van Campenhout, S. Crespo-Yanguas, A. Cooreman, E. Gijbels, K. Leroy, V. Vilas-Boas, N. Devoogdt, S. Muyldermans, B. Cogliati, M. Vinken (2019). Increased expression of adherens junction components in mouse liver following bile duct ligation. Biomolecules 9(10): 636
2019
V. Vilas-Boas, E. Gijbels, A. Cooreman, R. Van Campenhout, E. Gustafson, K. Leroy, M. Vinken (2019). Industrial, biocide and cosmetic chemical inducers of cholestasis. Chemical Research in Toxicology 32:1327-1334
E. Gijbels, V. Vilas-Boas, N. Deferm, L. Devisscher, H. Jaeschke, P. Annaert, M. Vinken (2019). Mechanisms and in vitro models of drug‑induced cholestasis. Archives of Toxicology 93:1169–1186
V. Vilas-Boas*, A. Cooreman*, E. Gijbels, R. Van Campenhout, E. Gustafson, S. Ballet, P. Annaert, B. Cogliati, M. Vinken (2019). Primary hepatocytes and their cultures for the testing of drug-induced liver injury. Book chapter in Advances in Pharmacology: 85:1-30 (*co-first authors)